Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase NA 2Phase 3 1Phase 1 1

Status

Withdrawn 1Completed 1

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 2

Sponsor

Conditions

Neuroectodermal Tumors, Primitive, Peripheral 2Neuroblastoma 2Retinoblastoma 1Ovarian Neoplasms 1Lymphoma 1Central Nervous System Neoplasms 1

Interventions

Etoposide 3trioctyl phosphine oxide 2indolepropanol phosphate 2Topotecan 2Melphalan 2Ifosfamide 2Cyclophosphamide 2Busulfan 2Whole-Body Irradiation 1Vincristine 1Transplantation 1Thiotepa 1Radiotherapy, Intensity-Modulated 1Radiotherapy 1Radiation 1Peripheral Blood Stem Cell Transplantation 1Pentetic Acid 1Minocycline 1Magnetic Resonance Spectroscopy 1Liquid Biopsy 1Heparin 1Granulocyte Colony-Stimulating Factor 1Glutamine 1Gelclair 1Filgrastim 1Electroacupuncture 1Doxorubicin 1Carmustine 1Carboplatin 1Bone Marrow Transplantation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Neuroectodermal Tumors, Primitive, Peripheral × Topotecan × Clear all
NCT01795430 2015-01-09

Whole-Body Radiation Therapy, Systemic Chemotherapy, and High-Dose Chemotherapy Followed By Stem Cell Rescue in Treating Patients With Poor-Risk Ewing Sarcoma

City of Hope Medical Center

Phase NA Withdrawn

Neuroectodermal Tumors, Primitive, Peripheral

NCT00618813 2014-09-25

Two Regimens of Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed Localized Ewing Sarcoma Family of Tumors

Children's Oncology Group

Phase NA Completed
35 enrolled 11 charts

Neuroectodermal Tumors, Primitive, Peripheral

Data powered by HemOnc (CC BY 4.0) Colophon âš¡